BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Preprint from Northwestern University Highlights Complementary Proteomic Analysis of Interleukin-6 Using Next-Generation Protein Sequencing™ and Mass Spectrometry

  February 12, 2025

   · 

  5 min read
• Press Releases

  Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial

  February 12, 2025

   · 

  6 min read
• Press Releases

  Molecular Instruments’® RNA In Situ Hybridization (RNA-ISH) Technology Enables Breakthrough Laboratory-Developed Tests (LDTs) to Advance Precision Medicine for Inflammatory Skin Disease

  February 12, 2025

   · 

  4 min read
• Press Releases

  NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

  February 12, 2025

   · 

  11 min read
• Press Releases

  Over 10,000 Procedures Completed in U.S. with Centinel Spine’s Match-the-Disc™ prodisc® Cervical Total Disc Replacement System

  February 12, 2025

   · 

  3 min read
• Press Releases

  PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

  February 12, 2025

   · 

  12 min read
• Press Releases

  OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod

  February 12, 2025

   · 

  4 min read
• Press Releases

  Access Vascular Catheters with MIMIX® Technology Added to Recon Supply’s Federal Supply Schedule Contract

  February 12, 2025

   · 

  3 min read
• Press Releases

  Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with Glyph™ Platform

  February 12, 2025

   · 

  4 min read
• Press Releases

  Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

  February 12, 2025

   · 

  7 min read